Home > Insider Trading > Filing (0000899243-22-015866)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1851657	Vaxxinity Inc.	VAXX	Medicinal Chemicals & Botanical Products (2833)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
896839	United Biomedical Inc	25 Davids Drive Hauppauge NY 11788		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2022-04-26	18,105	$3.45	51,611,559	No	4	P	Direct
Class A Common Stock	Acquisiton	2022-04-27	4,807	$3.58	51,616,366	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	4,212,495	Indirect	Held by United Biomedical Inc., Asia

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported is a weighted average price.
This number reflects an update and a correction from Reporting Person's Form 4 filed April 27, 2022, which should have reported that the Reporting Person beneficially owned 51,593,454 shares of Class A common stock instead of 5,193,454 shares of Class A common stock, which was accidentally reported.
Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.